AMNEAL PHARMACEUTICALS, INC., 8-K/A filed on 12/15/2023
Amended Current report filing
v3.23.3
Document and Entity Information
Nov. 07, 2023
Cover [Abstract]  
Amendment Flag true
Entity Central Index Key 0001723128
Document Type 8-K/A
Document Period End Date Nov. 07, 2023
Entity Registrant Name AMNEAL PHARMACEUTICALS, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-38485
Entity Tax Identification Number 93-4225266
Entity Address, Address Line One 400 Crossing Blvd
Entity Address, City or Town Bridgewater
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08807
City Area Code (908)
Local Phone Number 947-3120
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Class A Common Stock, par value $0.01 per share
Trading Symbol AMRX
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Description This Form 8-K/A is filed as an amendment to the Current Report on Form 8-K filed by Amneal Pharmaceuticals, Inc. on November 8, 2023 (the “Original Form 8-K”) solely in order to file a corrected Exhibit 3.2 to the Original Form 8-K (which supersedes and replaces in its entirety Exhibit 3.2 to the Original Form 8-K). Other than such correction, there are no other changes to the Original Form 8-K.